InvestorsHub Logo
Followers 20
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: None

Monday, 01/22/2018 2:00:51 PM

Monday, January 22, 2018 2:00:51 PM

Post# of 699494
After reading comments regarding the ASM...

A breakout of this stock from the 0.16-0.18 level occurred around Nov 15th. At the ASM, it was shared that the blinded data journal submission happened sometime this past fall with 65 co-authors. So there are 65 people who have access to this peer submitted journal data with no restrictions on trading in this company. So why did a breakout occur on Nov. 15th? I'd bet there are 65 scientist physicians who know why and a few others who are peer reviewing the submission who know why too.

There are so many dynamics in play with this equity and sometimes this investment feels like the makings of a good novel. You've got the people researching a new method to cure cancer, the people trying to make loads of money betting on the scientific failure, the reporters, the early investors, the late investors, the Twitter squawkers, and the legendary Cofer Black on the board of directors investigating. All we need is a happy ending here. It goes like this:

Great P3 results and DCVAX making inroads against one of the most lethal forms of cancer, the hedge funds getting prosecuted by the SEC for illegal naked shorting and paying billions in fines, and a share price rise that rewards the capitalists that hung in there for the duration. Who's going to write this book and which villain actor will portray Adam Feuerstein in the movie?

I'm enjoying the ride here...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News